{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:02:35Z","timestamp":1761807755597},"publisher-location":"Vienna","reference-count":54,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783211832615"},{"type":"electronic","value":"9783709163696"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-3-7091-6369-6_6","type":"book-chapter","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T23:50:18Z","timestamp":1343519418000},"page":"57-70","source":"Crossref","is-referenced-by-count":2,"title":["Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity"],"prefix":"10.1007","author":[{"given":"E.","family":"Gr\u00fcnblatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B. H.","family":"Youdim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/taap.1993.1048","volume":"119","author":"GM Adamson","year":"1993","unstructured":"Adamson GM, Billings RE (1993) Cytokine toxicity and induction of NO synthesis activity in cultured mouse hepatocytes. Toxicol Appl Pharmacol 119: 100\u2013107.","journal-title":"Toxicol Appl Pharmacol"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/j.1471-4159.1991.tb06432.x","volume":"57","author":"D Ben-Shachar","year":"1991","unstructured":"Ben-Shachar D, Youdim MBH (1991) Intranigral iron injection induces behavioral and biochemical \u201cparkinsonism\u201d in rats. J Neurochem 57: 2133\u20132135.","journal-title":"J Neurochem"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1471-4159.1991.tb11444.x","volume":"56","author":"D Ben-Shachar","year":"1991","unstructured":"Ben-Shachar D, Eshel G, Finberg JPM, Youdim MBH (1991) The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal neurons. J Neurochem 56: 1441\u20131444.","journal-title":"J Neurochem"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"10438","DOI":"10.1016\/S0021-9258(18)60979-2","volume":"262","author":"JM Braughler","year":"1987","unstructured":"Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobson EJ, McCall JM (1987) Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262: 10438\u201310440.","journal-title":"J Biol Chem"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0006-8993(89)91530-8","volume":"476","author":"JL Cadet","year":"1989","unstructured":"Cadet JL, Katz M, Jackson-Lewis V, Fahn S (1989) Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res 476: 5\u201310.","journal-title":"Brain Res"},{"key":"6_CR6","first-page":"139","volume-title":"Neurodegenerative disorders","author":"G Cohen","year":"1994","unstructured":"Cohen G, Werner P (1994) Free radicals oxidative stress and neurodegeneration. In: Calne DB (ed) Neurodegenerative disorders. Saunders, Philadelphia, pp 139\u2013162."},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/jnnp.64.5.573","volume":"64","author":"A Colzi","year":"1998","unstructured":"Colzi A, Turner K, Lee AJ (1998) Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 64: 573\u2013576.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0006-291X(87)91089-8","volume":"148","author":"MD Di","year":"1987","unstructured":"Di Monte D, Dandy MS, Smith MT (1987) Increase efflux rather than oxidation is the mechanism of glutathione dspletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem Biophys Res Commun 148: 153\u2013160.","journal-title":"Biochem Biophys Res Commun"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0301-0082(95)00029-1","volume":"48","author":"M Ebadi","year":"1996","unstructured":"Ebadi M, Srinivasan Sk, Baxi MD (1996) Oxidative stress and antioxidant therapy in Parkinson\u2019s disease. Prog Neurobiol 48: 1\u201319.","journal-title":"Prog Neurobiol"},{"key":"6_CR10","first-page":"137","volume":"45","author":"S Gancher","year":"1995","unstructured":"Gancher S (1995) Pharmacokinetics of apomorphine in Parkinson\u2019s disease. J Neural Transm [Suppl] 45: 137\u2013141.","journal-title":"J Neural Transm [Suppl]"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/mds.870100108","volume":"10","author":"ST Gancher","year":"1995","unstructured":"Gancher ST, Nutt JG, Woodward WR (1995) Apomorphine infusional therapy in Parkinson\u2019s disease: clinical utility and lack of tolerance. Mov Disord 10: 37\u201343.","journal-title":"Mov Disord"},{"key":"6_CR12","doi-asserted-by":"crossref","unstructured":"Gassen M, Youdim MBH (1998) Free radical scavengers: chemical concepts and clinical relevance. J Neural Transm (In press).","DOI":"10.1007\/978-3-7091-6360-3_13"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0014-2999(96)00291-9","volume":"308","author":"M Gassen","year":"1996","unstructured":"Gassen M, Glinka Y, Pinchasi B, Youdim MBH (1996) Apomorphine is highly potent free radical scavenger in rat mitochondrial fraction. Eur J Pharmacol 308: 219\u2013225.","journal-title":"Eur J Pharmacol"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.870130208","volume":"13","author":"M Gassen","year":"1998","unstructured":"Gassen M, Gross A, Youdim MBH (1998a) Apomorphine enantiomers protect pheochromocytoma (PC12) cells from oxidative stress induced by hydrogen peroxide and 6-hydroxydopamine. Mov Disord 13: 242\u2013248.","journal-title":"Mov Disord"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1054-3589(08)60754-1","volume":"42","author":"M Gassen","year":"1998","unstructured":"Gassen M, Pinchasi B, Youdim MBH (1998b) Apomorphine is a potent radical scavenger and protects culture pheochromocytoma cells from 6-OHDA and H2O2-induced cell death. Adv Pharmacol 42: 320\u2013324.","journal-title":"Adv Pharmacol"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1471-4159.1994.63030793.x","volume":"63","author":"M Gerlach","year":"1994","unstructured":"Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63: 793\u2013806.","journal-title":"J Neurochem"},{"key":"6_CR17","first-page":"329","volume":"292","author":"Y Glinka","year":"1995","unstructured":"Glinka Y, Youdim MBH (1995) Inhibition of mitochondrial complex I and IV by 6-hydroxydopamine. Euro J Pharmacol 292: 329\u2013332.","journal-title":"Euro J Pharmacol"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1046\/j.1471-4159.1996.66052004.x","volume":"66","author":"Y Glinka","year":"1996","unstructured":"Glinka Y, Tipton KF, Youdim MBH (1996) Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J Neurochem 66: 2004\u20132010.","journal-title":"J Neurochem"},{"key":"6_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","volume":"50","author":"Y Glinka","year":"1997","unstructured":"Glinka Y, Gassen M, Youdim MBH (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm [Suppl] 50: 55\u201366.","journal-title":"J Neural Transm [Suppl]"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0076-6879(87)47111-5","volume":"147","author":"LA Greene","year":"1987","unstructured":"Greene LA, Aletta JM, Rukenstein A, Green SH (1987) PC12 pheocytoma cells, culture, nerve growth factor treatment and experimental exploitation. Methods Enzymol 147: 207\u2013216.","journal-title":"Methods Enzymol"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/311467a0","volume":"311","author":"RE Heikkila","year":"1984","unstructured":"Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC (1984) Protection against the dopaminergic neurotoxicity of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311: 467\u2013469.","journal-title":"Nature"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF02252926","volume":"2","author":"K Jellinger","year":"1990","unstructured":"Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MBH (1990) Brain iron and ferritin in Parkinson\u2019s and Alzheimer\u2019s diseases. J Neural Transm [PD Sect] 2: 327\u2013340.","journal-title":"J Neural Transm [PD Sect]"},{"key":"6_CR23","first-page":"24","volume-title":"Neurodegeneration and neuroprotection in Parkinson\u2019s disease","author":"P Jenner","year":"1996","unstructured":"Jenner P, Olanow CW (1996) Pathological evidence for oxidative stress in Parkinson\u2019s disease and related degenerative disorders. In: Olanow CW, Jenner P, Youdim MBH (eds) Neurodegeneration and neuroprotection in Parkinson\u2019s disease. Academic Press, London, pp 24\u201345."},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/BF01985652","volume":"37","author":"T Kato","year":"1981","unstructured":"Kato T, Horiuchi S, Togari A, Nagatsu T (1981) A sensitive and inexpensive highperformance liquid Chromatographic assay for tyrosine hydroxylase. Experientia 37: 809\u2013811.","journal-title":"Experientia"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF01277665","volume":"104","author":"J Lan","year":"1997","unstructured":"Lan J, Jiang DH (1997) Desferrioxamine and vitamin E protect aginst iron and MPTP-induced neurodegeneration in mice. J Neural Transm 104: 469\u2013481.","journal-title":"J Neural Transm"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1472-8206.1993.tb00226.x","volume":"7","author":"AJ Lees","year":"1993","unstructured":"Lees AJ (1993) Dopamine agonists in Parkinson\u2019s disease: a look at apomorphine. Fundam Clin Pharmacol 7: 121\u2013128.","journal-title":"Fundam Clin Pharmacol"},{"key":"6_CR27","first-page":"171","volume":"43","author":"PA LeWitt","year":"1994","unstructured":"LeWitt PA (1994) Clinical trials of neuroprotection in Parkinson\u2019s disease: long-term Selegiline and alpha-tocopherol treatment. J Neural Transm [Suppl] 43: 171\u2013181.","journal-title":"J Neural Transm [Suppl]"},{"key":"6_CR28","first-page":"160","volume":"1316","author":"W Linert","year":"1996","unstructured":"Linert W, Herlinger E, Jameson RF, Kienzl E, Jellinger K, Youdim MBH (1996) Dopamine, 6-hydroxydopamine, iron, and dioxygen-their mutual interactions and possible implication in the development of Parkinson\u2019s disease. Biochem Biophys Acta 1316: 160\u2013168.","journal-title":"Biochem Biophys Acta"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1006\/abbi.1993.1189","volume":"302","author":"J Liu","year":"1993","unstructured":"Liu J, Mori A (1993) Monoamine metabolism provides an antioxidant defense in the brain against oxidant-and free radical-induced damage. Arch Biochem Biophys 302: 118\u2013127.","journal-title":"Arch Biochem Biophys"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1006\/exnr.1996.6406","volume":"143","author":"RT Matthews","year":"1997","unstructured":"Matthews RT, Yang L, Beal M (1997) S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp Neurol 143: 282\u2013286.","journal-title":"Exp Neurol"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0304-3940(94)90462-6","volume":"168","author":"H Mochizuki","year":"1994","unstructured":"Mochizuki H, Imai H, Endo K, Yokomizo K, Murata Y, Hattori N, Mizuno Y (1994) Iron accumulation in the substantia nigra of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced hemiparkinsonism in monkeys. Neurosci Lett 168: 251\u2013253.","journal-title":"Neurosci Lett"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1016\/0006-2952(89)90512-1","volume":"38","author":"HP Monteiro","year":"1989","unstructured":"Monteiro HP, Winterbourn CC (1989) 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochem Pharmacol 38: 4177\u20134182.","journal-title":"Biochem Pharmacol"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/BF00500765","volume":"322","author":"AM O\u2019Carroll","year":"1983","unstructured":"O\u2019Carroll AM, Fowler CJ, Phillips JP, Tobbia I, Tipton KF (1983) The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn Schmiedebergs Arch Pharmacol 322: 198\u2013202.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0006-8993(94)90833-8","volume":"660","author":"E Oestreicher","year":"1994","unstructured":"Oestreicher E, Sengstock GJ, Riederer P, Olanow CW, Dunn AJ, Arendash GW (1994) Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study. Brain Res 660: 8\u201318.","journal-title":"Brain Res"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF01245230","volume":"91","author":"CW Olanow","year":"1993","unstructured":"Olanow CW (1993) A scientific rationale for protective therapy in Parkinson\u2019s disease. J Neural Transm [Gen. Sect] 91: 161\u2013180.","journal-title":"J Neural Transm [Gen. Sect]"},{"key":"6_CR36","first-page":"50","volume-title":"Neurodegeneration and neuroprotection in Parkinson\u2019s disease","author":"CW Olanow","year":"1996","unstructured":"Olanow CW, Youdim MBH (1996) Iron and neurodegeneration: Prospects for neuroprotection. In: Olanow CW, Jenner P, Youdim MBH (eds) Neurodegeneration and neuroprotection in Parkinson\u2019s disease. Academic Press, New York, pp 50\u201367."},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0361-9230(92)90142-K","volume":"29","author":"AS Perumal","year":"1992","unstructured":"Perumal AS, Gopal VB, Tordzro WK, Cooper TB, Cadet JL (1992) Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res Bull 29: 699\u2013701.","journal-title":"Brain Res Bull"},{"key":"6_CR38","first-page":"163","volume":"43","author":"H Przuntek","year":"1994","unstructured":"Przuntek H (1994) Clinical aspects of neuroprotection in Parkinson\u2019s disease. J Neural Transm [Suppl] 43: 163\u2013169.","journal-title":"J Neural Transm [Suppl]"},{"key":"6_CR39","doi-asserted-by":"crossref","first-page":"14572","DOI":"10.1016\/S0021-9258(18)77341-9","volume":"265","author":"JT Rogers","year":"1990","unstructured":"Rogers JT, Bridges KR, Durmowicz GP, Glass J, Zuron PE, Munro HN (1990) Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. J Biol Chem 265: 14572\u201314578.","journal-title":"J Biol Chem"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF02251227","volume":"10","author":"EE Sam","year":"1995","unstructured":"Sam EE, Verbeke N (1995) Free radical scavenging properties of apomorphine enantiomers and dopamine \u2014 possible implication in their mechanism of action in parkinsonism. J Neural Transm [PD Sect] 10: 115\u2013127.","journal-title":"J Neural Transm [PD Sect]"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF03192285","volume":"20","author":"E Sam","year":"1995","unstructured":"Sam E, Jeanjean AP, Maloteaux JM, Verbeke N (1995) Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application. Eur J Drug Metab Parmacokinet 20: 27\u201333.","journal-title":"Eur J Drug Metab Parmacokinet"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1471-4159.1997.68020732.x","volume":"68","author":"M Santiago","year":"1997","unstructured":"Santiago M, Matarredona ER, Granero L, Cano J, Machado A (1997) Neuroprotective effect of the iron chelator desferrioxamine against MPP+ toxicity on striatal dopaminergic terminals. J Neurochem 68: 732\u2013738.","journal-title":"J Neurochem"},{"key":"6_CR43","doi-asserted-by":"crossref","first-page":"13074","DOI":"10.1016\/S0021-9258(19)38621-1","volume":"268","author":"C Seiser","year":"1993","unstructured":"Seiser C, Teixeira S, Kuhn LC (1993) Interleukin-2 dependent transcriptional and posttranscriptional regulation of transferrin receptor mRNA, J Biol Chem 268: 13074\u201313080.","journal-title":"J Biol Chem"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/exnr.1994.1187","volume":"130","author":"GJ Sengstock","year":"1994","unstructured":"Sengstock GJ, Olanow CW, Dunn AJ, Barone S Jr, Arendash GW (1994) Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra. Exp Neurol 130: 82\u201394.","journal-title":"Exp Neurol"},{"key":"6_CR45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1165\/ajrcmb.12.6.7539275","volume":"12","author":"PP Simeonova","year":"1995","unstructured":"Simeonova PP, Luster MI (1995) Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. Am J Respir Cell Mol Biol 12: 676\u2013683.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.1987.tb03384.x","volume":"49","author":"TP Singer","year":"1987","unstructured":"Singer TP, Castagnoli N Jr, Ramsay RR, Treor AJ (1987) Biochemical events in the development of parkinsonism induced by l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. J Neurochem 49: 1\u20138.","journal-title":"J Neurochem"},{"key":"6_CR47","first-page":"185","volume":"20","author":"V Sorrenti","year":"1994","unstructured":"Sorrenti V, Di Giacomo C, Renis M, Russo A, La Delfa C, Perez-Polo JR, Vanella A (1994) Lipid peroxidation and survival in rats following cerebral post-ischemic reperfusion: effect of drugs with different molecular mechanisms. Drugs Exp Clin Res 20: 185\u2013189.","journal-title":"Drugs Exp Clin Res"},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1146\/annurev.bi.62.070193.004053","volume":"62","author":"ER Stadtman","year":"1993","unstructured":"Stadtman ER (1993) Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 62: 797\u2013821.","journal-title":"Annu Rev Biochem"},{"key":"6_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1046\/j.1471-4159.1994.62010134.x","volume":"62","author":"JA Temlett","year":"1994","unstructured":"Temlett JA, Landsberg JP, Watt F, Grime GW (1994) Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian african green monkey: evidence from proton microprobe element microanalysis. J Neurochem 62: 134\u2013146.","journal-title":"J Neurochem"},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/0006-2952(96)00065-2","volume":"51","author":"F Vimard","year":"1996","unstructured":"Vimard F, Nouvelot A, Duval D (1996) Cytotoxic effects of oxidative stress on neuronallike pheochromocytoma cells. Biochem Pharmacol 51: 1389\u20131395.","journal-title":"Biochem Pharmacol"},{"key":"6_CR51","first-page":"239","volume":"32","author":"MBH Youdim","year":"1990","unstructured":"Youdim MBH, Ben-Shachar D, Riederer P (1990) The role of monoamine oxidase, ironmelanin interaction, and intracellular calcium in Parkinson\u2019s disease. J Neural Transm [Suppl] 32: 239\u2013248.","journal-title":"J Neural Transm [Suppl]"},{"key":"6_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mds.870080102","volume":"8","author":"MBH Youdim","year":"1993","unstructured":"Youdim MBH, Ben-Shachar D, Riederer P (1993) The possible role of iron in the etiopathology of Parkinson\u2019s disease. Mov Disord 8: 1\u201312.","journal-title":"Mov Disord"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0891-5849(95)00007-K","volume":"19","author":"W Zhao","year":"1995","unstructured":"Zhao W, Richardson JS, Mombourquette MJ, Weil JA (1995) An in vitro EPR study of the free-radical scavenging action of the lazaroid antioxidants U-74500A and U-78517F. Free Radic Biol Med 19: 21\u201330.","journal-title":"Free Radic Biol Med"},{"key":"6_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF03159728","volume":"10","author":"MJ Zigmond","year":"1989","unstructured":"Zigmond MJ, Berger TW, Grace AA, Stricker EM (1989) Compensatory responses to nigrostriatal bundle injury. Mol Chem Neuropathol 10: 185\u2013200.","journal-title":"Mol Chem Neuropathol"}],"container-title":["Advances in Research on Neurodegeneration"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-6369-6_6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T04:57:54Z","timestamp":1643000274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-6369-6_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9783211832615","9783709163696"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-6369-6_6","relation":{},"subject":[],"published":{"date-parts":[[1999]]}}}